Anastassia Hatzoglou

Prof. Dr. Anastassia Hatzoglou

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 March 2017 in Science Signaling
Verified
Journal Article
Closed access
PDF file
GAGuillaume Andrieu
Guillaume Andrieu
ALAdeline Ledoux
Adeline Ledoux
SBSophie Branka
Sophie Branka
MBMagalie Bocquet
Magalie Bocquet
JGJulia Gilhodes
Julia Gilhodes
AHAnastassia Hatzoglou
Anastassia Hatzoglou
Sphingosine kinase 1 (SphK1) promotes cell proliferation and survival, and its abundance is often increased in tumors. SphK1 produces the signaling lipid sphingosine 1-phosphate (S1P), which activates signaling cascades downstream five G protein–coupled receptors (S1P1–5) to modulate vascular and immune system function and promote proliferation. We identified a new function of the SphK1-S1P pathway specifically in the control of mitosis. SphK1 depletion in HeLa cells caused prometaphase arrest, whereas its overexpression or activation accelerated mitosis. Increasing the abundance of S1P promoted mitotic progression, overrode the spindle assembly checkpoint (SAC), and led to chromosome segregation defects. S1P was secreted through the transporter SPNS2 and stimulated mitosis by binding to and activating S1P5 on the extracellular side, which then activated the intracellular phosphatidylinositol 3-kinase (PI3K)–AKT pathway. Knockdown of S1P5 prevented the S1P-induced spindle defect phenotype. RNA interference assays revealed that the mitotic kinase Polo-like kinase 1 (PLK1) was an important effector of S1P-S1P5 signaling-induced mitosis in HeLa cells. Our findings identify an extracellular signal and the downstream pathway that promotes mitotic progression and may indicate potential therapeutic targets to inhibit the proliferation of cancer cells.

10 September 2012 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
GAGuillaume Andrieu
Guillaume Andrieu
MQMuriel Quaranta
Muriel Quaranta
CLCorinne Leprince
Corinne Leprince
AHAnastassia Hatzoglou
Anastassia Hatzoglou
Within the Ras superfamily, Gem is a small GTP‐binding protein that plays a role in regulating Ca 2+ channels and cytoskeletal remodeling in interphase cells. Here, we report for the first time that Gem is a spindle‐associated protein and is required for proper mitotic progression. Functionally, loss of Gem leads to misaligned chromosomes and prometaphase delay. On the basis of different experimental approaches, we demonstrate that loss of Gem by RNA interference induces spindle elongation, while its enforced expression results in spindle shortening. The spindle length phenotype is generated through deregulation of spindle dynamics on Gem depletion and requires the expression of its downstream effector, the kinesin Kif9. Loss of Kif9 induces spindle abnormalities similar to those observed when Gem expression is repressed by siRNA. We further identify Kif9 as a new regulator of spindle dynamics. Kif9 depletion increases the steady‐state levels of spindle α‐tubulin by increasing the rate of microtubule polymerization. Overall, this study demonstrates a novel mechanism by which Gem contributes to the mitotic progression by maintaining correct spindle length through the kinesin Kif9.—Andrieu, G., Quaranta, M., Leprince, C., Hatzoglou, A. The GTPase Gem and its partner Kif9 are required for chromosome alignment, spindle length control, and mitotic progression. FASEB J. 26, 5025–5034 (2012). www.fasebj.org

30 August 2014 in Carcinogenesis
Verified
Journal Article
Open access
PDF file
GAGuillaume Andrieu
Guillaume Andrieu
MQMuriel Quaranta
Muriel Quaranta
CLCorinne Leprince
Corinne Leprince
OCOLIVIER CUVILLIER
OLIVIER CUVILLIER
AHAnastassia Hatzoglou
Anastassia Hatzoglou
Gem is a small guanosine triphosphate (GTP)-binding protein within the Ras superfamily, involved in the regulation of voltage-gated calcium channel activity and cytoskeleton reorganization. Gem overexpression leads to stress fiber disruption, actin and cell shape remodeling and neurite elongation in interphase cells. In this study, we show that Gem plays a crucial role in the regulation of cortical actin cytoskeleton that undergoes active remodeling during mitosis. Ectopic expression of Gem leads to cortical actin disruption and spindle mispositioning during metaphase. The regulation of spindle positioning by Gem involves its downstream effector Gmip. Knockdown of Gmip rescued Gem-induced spindle phenotype, although both Gem and Gmip accumulated at the cell cortex. In addition, we implicated RhoA GTPase as an important effector of Gem/Gmip signaling. Inactivation of RhoA by overexpressing dominant-negative mutant prevented normal spindle positioning. Introduction of active RhoA rescued the actin and spindle positioning defects caused by Gem or Gmip overexpression. These findings demonstrate a new role of Gem/Gmip/RhoA signaling in cortical actin regulation during early mitotic stages.

7 November 2017 in Oncotarget
Verified
Journal Article
Open access
OCOLIVIER CUVILLIER
OLIVIER CUVILLIER
AHAnastassia Hatzoglou
Anastassia Hatzoglou

25 March 2022 in Cancers
Verified
Journal Article
Open access
PDF file
Franck TalmontFranck Talmont
Franck Talmont
EMElodie Mitri
Elodie Mitri
CDChristine Dozier
Christine Dozier
ABArnaud Besson
Arnaud Besson
OCOLIVIER CUVILLIER
OLIVIER CUVILLIER
AHAnastassia Hatzoglou
Anastassia Hatzoglou
Sphingosine 1-phosphate (S1P), a bioactive lipid, interacts with five widely expressed G protein-coupled receptors (S1P1-5), regulating a variety of downstream signaling pathways with overlapping but also opposing functions. To date, data regarding the role of S1P5 in cell proliferation are ambiguous, and its role in controlling the growth of untransformed cells remains to be fully elucidated. In this study, we examined the effects of S1P5 deficiency on mouse embryonic fibroblasts (MEFs). Our results indicate that lack of S1P5 expression profoundly affects cell morphology and proliferation. First, S1P5 deficiency reduces cellular senescence and promotes MEF immortalization. Second, it decreases cell size and leads to cell elongation, which is accompanied by decreased cell spreading and migration. Third, it increases proliferation rate, a phenotype rescued by the reintroduction of exogenous S1P5. Mechanistically, S1P5 promotes the activation of FAK, controlling cell spreading and adhesion while the anti-proliferative function of the S1P/S1P5 signaling is associated with reduced nuclear accumulation of activated ERK. Our results suggest that S1P5 opposes the growth-promoting function of S1P1-3 through spatial control of ERK activation and provides new insights into the anti-proliferative function of S1P5.

9 February 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
LRLeo Rolland
Leo Rolland
EMElodie Mitri
Elodie Mitri
CDChristine Dozier
Christine Dozier
MAMarion Aguirrebengoa
Marion Aguirrebengoa
INIvan Nemazanyy
Ivan Nemazanyy
ABArnaud Besson
Arnaud Besson
The metabolic needs of a cell are tightly linked to its proliferative state and increasing evidence indicate an extensive bidirectional crosstalk between metabolic pathways and cell cycle regulators. In cancer cells, metabolism is reprogrammed to couple energetic needs and relentless proliferation. The cyclin/CDK inhibitor p27 Kip1 (p27) is frequently inactivated in cancers. p27 is also involved in multiple cellular processes, including transcriptional regulation or autophagy induction. Herein, we investigated the effect of p27 loss on cell metabolism. The knockout of p27 in immortalized mouse fibroblasts increases glucose uptake and glycolysis, while decreasing mitochondrial ATP production, consistent with induction of a Warburg effect, and this was accompanied by an increased glutamine dependency to feed the TCA cycle. Our data suggest that p27 loss causes this phenotype through extensive transcriptional remodeling of metabolic gene expression. Importantly, p27 silencing in human retinal RPE1-hTERT cells was sufficient to induce a Warburg effect. Together, these results reveal a new function of p27 in regulating energy metabolism and that loss of p27 expression is sufficient to induce metabolic reprogramming and a Warburg effect, suggesting that p27 inactivation in cancer cells not only results in the loss of cell cycle inhibition but also enables the metabolic rewiring needed for increased proliferation.